- Joined
- Sep 9, 2004
- Messages
- 7,132
- Reaction score
- 1,255
Im finding myself describing the microscopic features of cases less and less. Im predicting in a few years that micro descriptions will be obsolete replaced with a combination of synoptic reporting formats and embedded images.
I can no longer see the value in mentioning the "blue myxoid-appearing stroma" of a fibroadenoma or the "marked nuclear pleomorphism with prominent inclusion-like nucleoli" of a metastatic melanoma. And I dont think clinicians care.
Someone asked on another thread how vastly more volume is being done by fewer and fewer pathologists and this is how. PAs are grossing, gallbladders are being bottom lined with canned texts and new breast cancers are being signed out as "Infiltrating ductal carcinoma, favor grade 2, no evidence of an in situ component or angiolymphatic invasion" with no description(for a core biopsy specimen).
I cannot see how people are really justifying spending the time to describe Owl's eye nuclear features, ropey collagenous stroma etc...
I can no longer see the value in mentioning the "blue myxoid-appearing stroma" of a fibroadenoma or the "marked nuclear pleomorphism with prominent inclusion-like nucleoli" of a metastatic melanoma. And I dont think clinicians care.
Someone asked on another thread how vastly more volume is being done by fewer and fewer pathologists and this is how. PAs are grossing, gallbladders are being bottom lined with canned texts and new breast cancers are being signed out as "Infiltrating ductal carcinoma, favor grade 2, no evidence of an in situ component or angiolymphatic invasion" with no description(for a core biopsy specimen).
I cannot see how people are really justifying spending the time to describe Owl's eye nuclear features, ropey collagenous stroma etc...